Perceptive Advisors LLC 13D and 13G filings for Leap Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
2023-02-14 2:30 pm Sale | 2022-12-31 | 13G | Leap Therapeutics, Inc. LPTX | Perceptive Advisors LLC | 672,650 6.800% | -175,000![]() (-20.65%) | Filing |
2022-02-14 6:55 pm Unchanged | 2021-12-31 | 13G | Leap Therapeutics, Inc. LPTX | Perceptive Advisors LLC | 847,650 9.600% | 0 (Unchanged) | Filing |
2021-02-16 3:42 pm Purchase | 2020-12-31 | 13G | Leap Therapeutics, Inc. LPTX | Perceptive Advisors LLC | 847,650 14.200% | 175,000![]() (+26.02%) | Filing |
2020-04-20 5:25 pm Purchase | 2020-03-09 | 13G | Leap Therapeutics, Inc. LPTX | Perceptive Advisors LLC | 672,650 18.800% | 672,650![]() (New Position) | Filing |